explore -WSS

explore

author：hotspot 2025-09-14 08:29:33 - browse：9

Adobe

The medical device industry is split on whether a proposed new Medicare reimbursement pathway will do anything to soothe their insurance coverage woes.

Device makers have long complained that the unclear, rocky road to payment kills innovative companies. So they were thrilled when the Trump administration proposed a rule that would have guaranteed four years of Medicare coverage of approved devices deemed “breakthroughs” by the Food and Drug Administration. They hoped private payers would follow suit. But in 2021, under a new administration and a push for more device scrutiny, the Centers for Medicare and Medicaid pulled back on the idea, promising a replacement that would streamline coverage for innovative devices while ensuring safe, high-quality care.

The pathway put forth last week, called Transitional Coverage for Emerging Technologies (TCET), is only a notice, not yet a rule that would grant CMS new powers. The program applies solely to devices that have earned a place in the FDA’s breakthrough device program, which was established to identify devices that the agency believed could provide “more effective” treatment or diagnosis of serious conditions than the current standard of care. But because those devices can be brought to market with less certainty in their benefits and risks than other products, experts said, the idea of automatic reimbursement was dicey.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： RaDonda Vaught links Vanderbilt hospital issues to patient death

explore

knowledge

WSS

There’s no way to know how good AI health technologies are

Akero's treatment for NASH falls short in cirrhosis study

EPA limits use of carcinogenic gas for sterilizing medical devices

Akero's treatment for NASH falls short in cirrhosis study

Boston's new lab space is opening empty

Researchers CRISPR chickens in bid to protect them from bird flu

knowledge

explore

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Amid AI frenzy, a top HHS official's quest to create safeguards

Novavax promises a turnaround & Lilly roils the obesity market

STAT Readout Newsletter: Today in biotech, life science news

Duchenne breakthrough therapy leaves behind pioneering families

Nick Jonas talks about managing diabetes along with his career

Affirmative action in medical school literally saved lives

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Hepatitis C has a cure — but many Americans still lack access to it

Steward Health Care Massachusetts hospitals face fiscal disaster

entertainment

Wellcome Trust names Røttingen as its new CEO

John Green on his newest strategy for fighting tuberculosis

European regulators consider appeal over Amylyx ALS drug

First U.S. drug developed to treat liver disease MASH is approved

Change Healthcare outage fallout shows need for new oversight

There’s no way to know how good AI health technologies are

focus

explore

knowledge

focus